A novel drug candidate to deter oxycodone abuse.
View complete product pipeline
October 10, 2014DURECT Announces POSIDUR™ (SABER®-Bupivacaine) Data Presentation at the American Society of Anesthesiologists Annual Meeting
August 25, 2014DURECT to Present at the Rodman & Renshaw Investment Conference
August 07, 2014DURECT Corporation Announces Second Quarter 2014 Financial Results and Update of Programs
July 30, 2014DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference Call